Clinical trial
A Phase 2 Open-label Trial to Evaluate the Efficacy and Safety of Rusfertide in Japanese Patients With Polycythemia Vera
NCT07648030 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Open-label Trial to Evaluate the Efficacy and Safety of Rusfertide in Japanese Patients With Polycythemia Vera
- Lead sponsor
- Takeda
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 14, 2026
- Completion date
- May 17, 2030
- Enrollment
- 9 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.